PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Ascariasis D001196 3 associated lipids
Thyroid Diseases D013959 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Erythema D004890 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Hyperlipidemias D006949 73 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Sasaguri T et al. Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. 1992 Exp. Cell Res. pmid:1572402
Kuchinke W et al. A lung type prostaglandin F synthase is expressed in bovine liver: cDNA sequence and expression in E. coli. 1992 Biochem. Biophys. Res. Commun. pmid:1339268
Ninomiya H et al. Endothelin-1 induces stimulation of prostaglandin synthesis in cells obtained from canine airways by bronchoalveolar lavage. 1992 Prostaglandins pmid:1584994
Krueger JM et al. Prostaglandins E2 and D2 have little effect on rabbit sleep. 1992 Physiol. Behav. pmid:1523224
Naclerio RM Additional properties of cetirizine, a new H1 antagonist. 1991 May-Jun Allergy Proc pmid:1680095
Lundin-Schiller S and Mitchell MD Prostaglandin production by human chorion laeve cells in response to inflammatory mediators. 1991 Jul-Aug Placenta pmid:1946245
Conde B et al. Modulation of cell growth and differentiation induced by prostaglandin D2 in the glioma cell line C6. 1991 Jan-Feb Anticancer Res. pmid:1902073
Giles H et al. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. 1991 Br. J. Pharmacol. pmid:1665742
Georgitis JW et al. Nasal inflammatory mediator release in ragweed allergic rhinitis: correlation with cellular influx into nasal secretions. 1991 Int. Arch. Allergy Appl. Immunol. pmid:1666629
Takayanagi I et al. Effects of aging on alpha 2-adrenoceptor mechanisms in isolated guinea-pig tracheal preparations. 1991 Eur. J. Pharmacol. pmid:1674919
Goerg KJ et al. Antisecretory effect of prostaglandin D2 in rat colon in vitro: action sites. 1991 Am. J. Physiol. pmid:1676243
Fox CC et al. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. 1991 Dig. Dis. Sci. pmid:1703070
Keenan CM and Rangachari PK Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. 1991 Am. J. Physiol. pmid:2003610
Roberts LJ and Oates JA Biochemical diagnosis of systemic mast cell disorders. 1991 J. Invest. Dermatol. pmid:16799604
Massey WA et al. Profile of prostanoid release following antigen challenge in vivo in the skin of man. 1991 Br. J. Dermatol. pmid:1760357
Shikada K et al. NIP-121 and cromakalim, potassium channel openers, preferentially suppress prostanoid-induced contraction of the guinea-pig isolated trachea. 1991 Eur. J. Pharmacol. pmid:1814761
Gaetani P et al. Effect of high-dose methylprednisolone and U74006F on eicosanoid synthesis after subarachnoid hemorrhage in rats. 1991 Stroke pmid:1900645
Brodsky L et al. Arachidonic acid metabolites in middle ear effusions of children. 1991 Ann. Otol. Rhinol. Laryngol. pmid:1648326
Weiler H et al. Studies on the effects of aminopterin and methotrexate on the release of prostaglandin PGE2, PGD2, and PGI2 from small intestine in the rat in vivo. 1991 Clin. Chim. Acta pmid:1769112
Watanabe T et al. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s. 1991 Blood pmid:1718495
Minc-Golomb D et al. Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice. 1991 EMBO J. pmid:1829676
Tasaki Y et al. Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification. 1991 Prostaglandins pmid:1871375
Vesin MF et al. Preferential synthesis of prostaglandin D2 by neurons and prostaglandin E2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia. 1991 J. Neurochem. pmid:2051162
Ramis I et al. In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions. 1991 Prostaglandins pmid:1662405
Fukushima M [Prostaglandins and cell proliferation]. 1991 Tanpakushitsu Kakusan Koso pmid:2024021
Hori T et al. Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor. 1991 Biochem. Biophys. Res. Commun. pmid:1993070
White MV et al. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE. 1991 J. Immunol. pmid:1712816
Stellato C et al. General anaesthetics induce only histamine release selectively from human mast cells. 1991 Br J Anaesth pmid:1722691
Walmrath D et al. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. 1991 J. Appl. Physiol. pmid:1723406
Vesin MF and Droz B Biosynthesis of prostaglandins D2 and E2 in chick dorsal root ganglion during development. 1991 J. Neurochem. pmid:1904909
Misawa M and Kanai Y Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs. 1991 Arzneimittelforschung pmid:1725697
Abman SH and Accurso FJ Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. 1991 Am. J. Physiol. pmid:1847014
Sladek K et al. Formation of PGD2 after allergen inhalation in atopic asthmatics. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1847781
King LS et al. Pulmonary vascular effects of prostaglandin D2, but not its systemic vascular or airway effects, are mediated through thromboxane receptor activation. 1991 Circ. Res. pmid:1825033
Arzubiaga C et al. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. 1991 J. Allergy Clin. Immunol. pmid:1825102
Koshihara Y et al. Prostaglandin D2 stimulates calcification by human osteoblastic cells. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825424
Atsmon J et al. Modulation of the antiproliferative activity of 9-deoxy-delta 9,delta 12(E)-PGD2 by conjugation with intracellular glutathione. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825432
Hayaishi O Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2. 1991 FASEB J. pmid:1907936
Koizumi K et al. Induction of 31,000 protein by PGD2-treated vascular endothelial cells. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825433
Morrow JD et al. A stable isotope dilution mass spectrometric assay for the major urinary metabolite of PGD2. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825560
Howarth P et al. The comparative nasal effects of prostaglandin D2 in normal and rhinitic subjects. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825579
Gundel RH et al. The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late-phase bronchoconstriction and cellular infiltrates in primates. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825582
Watanabe K et al. The structure and function of prostaglandin F synthase. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825592
Gebicke-Haerter PJ et al. Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. 1991 J. Neurochem. pmid:1828830
Francis HP et al. The thromboxane receptor antagonist BAY u3405 reverses prostaglandin D2 (PGD2)-induced bronchoconstriction in the anaesthetised guinea pig. 1991 Ann. N. Y. Acad. Sci. pmid:1835329
Kobayashi Y et al. Syntheses of 2,6-dideoxy-6-fluoro-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]-D- glucopyranose 4-(dihydrogen phosphate) and 2-deoxy-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]- alpha-D-glucopyranosyl fluoride 4-(dihydrogen phosphate): fluorosugar analogues of GLA-60. 1991 Carbohydr. Res. pmid:1813114
Murakami M et al. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. 1991 FEBS Lett. pmid:1756867
McMahon TJ et al. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 1991 J. Appl. Physiol. pmid:1837015
Ney P and Schrör K PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. 1991 Eicosanoids pmid:1647806
Smith GS et al. Adaptive cytoprotection against alcohol injury in the rat stomach is not due to increased prostanoid synthesis. 1991 Prostaglandins pmid:1906621